BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Amougou MA, Noah DN, Moundipa PF, Pineau P, Njouom R. A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa. BMC Infect Dis 2016;16:647. [PMID: 27821080 DOI: 10.1186/s12879-016-1992-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Diakite M, Shaw-saliba K, Lau C. Malignancy and viral infections in Sub-Saharan Africa: A review. Front Virol 2023;3. [DOI: 10.3389/fviro.2023.1103737] [Reference Citation Analysis]
2 Tan YW. Risk stratification of primary liver cancer. World J Clin Cases 2022; 10(26): 9545-9549 [DOI: 10.12998/wjcc.v10.i26.9545] [Reference Citation Analysis]
3 Monroy-Iglesias MJ, Crescioli S, Beckmann K, Le N, Karagiannis SN, Van Hemelrijck M, Santaolalla A. Antibodies as biomarkers for cancer risk: a systematic review. Clin Exp Immunol 2022;209:46-63. [PMID: 35380164 DOI: 10.1093/cei/uxac030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Stella L, Santopaolo F, Gasbarrini A, Pompili M, Ponziani FR. Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment. World J Gastroenterol 2022; 28(21): 2251-2281 [DOI: 10.3748/wjg.v28.i21.2251] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
5 Somé EN, Guingané NA, Ouédraogo H, Tarnagda G, Kouanda S, Sombié R. The hepatocellular carcinoma's risk factors among in-hospital patients at the university-teaching hospital Yalgado Ouédraogo in Ouagadougou, Burkina Faso: A case-control study. Clinical Epidemiology and Global Health 2022;13:100947. [DOI: 10.1016/j.cegh.2021.100947] [Reference Citation Analysis]
6 Dakurah OB, Tamandjou CRT, Zunza M, Preiser W, Maponga TG. Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic review. BMC Cancer 2021;21:715. [PMID: 34144696 DOI: 10.1186/s12885-021-08426-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
7 Rizzetto M, Hamid S, Negro F. The changing context of hepatitis D. J Hepatol 2021;74:1200-11. [PMID: 33484770 DOI: 10.1016/j.jhep.2021.01.014] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 26.5] [Reference Citation Analysis]
8 Ajayi BB, Latbone S, Igwegbe IU, Kida IM, Goni BW, Samuel OO, Dawurung JS, Ibrahim HM, Danue BA, Abdullahi IN, Oderinde BS. Serological detection of hepatitis B and D virus co-infection among patients attending a tertiary health facility at Maiduguri, Nigeria. Egypt J Intern Med 2021;33. [DOI: 10.1186/s43162-021-00036-1] [Reference Citation Analysis]
9 Ferrante ND, Lo Re V 3rd. Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection. Curr HIV/AIDS Rep. 2020;17:405-414. [PMID: 32607773 DOI: 10.1007/s11904-020-00508-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
10 Amougou-Atsama M, Jean Adrien Atangana P, Noah Noah D, Fewou Moundipa P, Pineau P, Njouom R. The role of hepatitis C virus genotypes and core mutations in hepatocellular carcinoma in Cameroon. J Viral Hepat 2020;27:880-5. [PMID: 32301239 DOI: 10.1111/jvh.13303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Baskiran A, Akbulut S, Sahin TT, Koc C, Karakas S, Ince V, Yurdaydin C, Yilmaz S. Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation. Hepatol Int 2020;14:869-880. [DOI: 10.1007/s12072-020-10085-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
12 Moussavou-boundzanga P, Mabika B, Itoudi Bignoumba PE, Marchio A, Mouinga-ondeme A, Moussavou Kombila J, Pineau P. Underestimation of hepatocellular carcinoma incidence resulting from a competition between modern and traditional medicine: the case of Gabon. Journal of Global Health Reports 2020;4. [DOI: 10.29392/001c.13653] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Sonderup MW, Dusheiko G, Desalegn H, Lemoine M, Tzeuton C, Taylor-Robinson SD, Spearman CW. Hepatitis B in sub-Saharan Africa-How many patients need therapy? J Viral Hepat 2020;27:560-7. [PMID: 31800145 DOI: 10.1111/jvh.13247] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Atsama Amougou M, Marchio A, Bivigou-Mboumba B, Noah Noah D, Banai R, Atangana PJA, Fewou Moundipa P, Pineau P, Njouom R. Enrichment in selected genotypes, basal core and precore mutations of hepatitis B virus in patients with hepatocellular carcinoma in Cameroon. J Viral Hepat 2019;26:1086-93. [PMID: 31106515 DOI: 10.1111/jvh.13131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
15 Marino Q, Cisse M, Gerber A, Dolo O, Sayon S, Ba A, Brichler S, Traore FT, Gordien E, Togo J, Calvez V, Marcelin AG, Maiga AI, Todesco E. Low hepatitis D seroprevalence in blood donors of Bamako, Mali. Infect Dis (Lond) 2019;51:622-4. [PMID: 31165648 DOI: 10.1080/23744235.2019.1620963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Puigvehí M, Moctezuma-Velázquez C, Villanueva A, Llovet JM. The oncogenic role of hepatitis delta virus in hepatocellular carcinoma. JHEP Rep 2019;1:120-30. [PMID: 32039360 DOI: 10.1016/j.jhepr.2019.05.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
17 Turcanu A, Pitel E, Dumbrava VT, Tcaciuc E, Donscaia A, Peltec A, Pineau P. Profile of hepatocellular carcinoma in the Republic of Moldova: first-hand information on the presentation, distribution and etiologies. Rom J Intern Med 2019;57:37-46. [PMID: 30375353 DOI: 10.2478/rjim-2018-0026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
18 Rizzetto M. Hepatitis D Virus. Clinical Epidemiology of Chronic Liver Diseases 2019. [DOI: 10.1007/978-3-319-94355-8_11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Butler EK, Rodgers MA, Coller KE, Barnaby D, Krilich E, Olivo A, Cassidy M, Mbanya D, Kaptue L, Ndembi N, Cloherty G. High prevalence of hepatitis delta virus in Cameroon. Sci Rep 2018;8:11617. [PMID: 30072752 DOI: 10.1038/s41598-018-30078-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
20 Romeo R, Petruzziello A, Pecheur EI, Facchetti F, Perbellini R, Galmozzi E, Khan NU, Di Capua L, Sabatino R, Botti G. Hepatitis delta virus and hepatocellular carcinoma: an update. Epidemiol Infect. 2018;146:1612-1618. [PMID: 29991359 DOI: 10.1017/s0950268818001942] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
21 Wang Y, Glenn JS, Winters MA, Shen LP, Choong I, Shi YL, Bi SL, Ma LY, Zeng H, Zhang FJ. A new dual-targeting real-time RT-PCR assay for hepatitis D virus RNA detection. Diagn Microbiol Infect Dis 2018;92:112-7. [PMID: 29941366 DOI: 10.1016/j.diagmicrobio.2018.05.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
22 Marchio A, Amougou Atsama M, Béré A, Komas NP, Noah Noah D, Atangana PJA, Camengo-Police SM, Njouom R, Bekondi C, Pineau P. Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma. Clin Exp Med 2018;18:421-31. [PMID: 29749584 DOI: 10.1007/s10238-018-0502-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
23 Jaquet A, Tchounga B, Tanon A, Bagny A, Ekouevi DK, Traore HA, Sasco AJ, Maiga M, Dabis F. Etiology of hepatocellular carcinoma in West Africa, a case-control study. Int J Cancer 2018;143:869-77. [PMID: 29569722 DOI: 10.1002/ijc.31393] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
24 Bivigou-Mboumba B, Amougou-Atsama M, Zoa-Assoumou S, M'boyis Kamdem H, Nzengui-Nzengui GF, Ndojyi-Mbiguino A, Njouom R, François-Souquière S. Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence. PLoS One 2018;13:e0190592. [PMID: 29315352 DOI: 10.1371/journal.pone.0190592] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
25 Luma HN, Eloumou SAFB, Okalla C, Donfack-Sontsa O, Koumitana R, Malongue A, Nko'Ayissi GB, Noah DN. Prevalence and Characteristics of Hepatitis Delta Virus Infection in a Tertiary Hospital Setting in Cameroon. J Clin Exp Hepatol 2017;7:334-9. [PMID: 29234199 DOI: 10.1016/j.jceh.2017.05.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
26 Didi-Kouko Coulibaly J, Yeboua M, Kouassi Mbengue A, Kouadio EA, Anzouan-Kacou Kissi H, Binan AY, Lohoues Kouacou MJ, Attia A, Yao DNA, Toutou T, Adoubi I, Pineau P. Evolution of hepatocellular carcinoma epidemiology in Côte d'Ivoire. Bull Cancer 2017;104:937-45. [PMID: 29128083 DOI: 10.1016/j.bulcan.2017.09.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
27 Trad D, Bibani N, Sabbah M, Elloumi H, Gargouri D, Ouakaa A, Kharrat J. Known, new and emerging risk factors of hepatocellular carcinoma (review). La Presse Médicale 2017;46:1000-7. [DOI: 10.1016/j.lpm.2017.09.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
28 Bigna JJ, Amougou MA, Asangbeh SL, Kenne AM, Nansseu JR. Seroprevalence of hepatitis C virus infection in Cameroon: a systematic review and meta-analysis. BMJ Open 2017;7:e015748. [PMID: 28851778 DOI: 10.1136/bmjopen-2016-015748] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
29 Amougou Atsama M, Atangana PJA, Noah Noah D, Moundipa PF, Pineau P, Njouom R. Hepatitis E virus infection as a promoting factor for hepatocellular carcinoma in Cameroon: Preliminary Observations. Int J Infect Dis. 2017;64:4-8. [PMID: 28847760 DOI: 10.1016/j.ijid.2017.08.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
30 Soriano V, Sherman KE, Barreiro P. Hepatitis delta and HIV infection. AIDS 2017;31:875-84. [PMID: 28121714 DOI: 10.1097/QAD.0000000000001424] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]